Report copyright - HIGHLIGHTS OF PRESCRIBING INFORMATION Permanently ... · Co-administration of rifampin (strong CYP3A4 inducer and moderate CYP2C8 inducer) decreased the composite AUC of enzalutamide
Please pass captcha verification before submit form